目的 了解带有死亡结构域的Fas相关蛋白（FADD）在维生素E琥珀酸酯（VES）诱导胃腺癌细胞凋亡过程中的作用。方法 以人胃腺癌SGC-7901细胞作为靶细胞,采用 Western Blot法、Lipofect转染法、DAPI染色法探讨FADD在VES诱导SGC-7901细胞凋...目的 了解带有死亡结构域的Fas相关蛋白（FADD）在维生素E琥珀酸酯（VES）诱导胃腺癌细胞凋亡过程中的作用。方法 以人胃腺癌SGC-7901细胞作为靶细胞,采用 Western Blot法、Lipofect转染法、DAPI染色法探讨FADD在VES诱导SGC-7901细胞凋亡过程中的作用。结果 经不同剂量VES处理后,SGC-7901细胞中FADD蛋白表达增加,呈剂量-效应关系;该细胞经FADD反义寡核苷酸转染与正义寡核苷酸转染相比,VES处理的细胞中FADD蛋白表达下降;用FADD反义寡核苷酸转染SGC-7901细胞后,降低了VES诱导的细胞凋亡率。结论FADD在VES诱导SGC-7901细胞凋亡过程中起着重要的作用。展开更多
Objective： The aim of this study was to detect apoptosis rates of Her-2 overexpression breast cancer cells, which were administrated with vitamin E succinate （VES） combined with paclitaxel at different dosages, or ...Objective： The aim of this study was to detect apoptosis rates of Her-2 overexpression breast cancer cells, which were administrated with vitamin E succinate （VES） combined with paclitaxel at different dosages, or administrated alone; to discuss the mechanism of their actions. Methods： Using immunohistochemical method to detect Her-2 expression of MDA- MB-453 cells. Using TUNEL assay to detect apoptosis rates of MDA-MB-453 ceils, with the concentrations at 10, 20 mg/L of VES and 50, 100 nmol/L of paclitaxel, and also combined together for 24 or 48 h. Then compared apoptosis action of various combinations. Results： The expression rate of 95% Her-2 was interval （63.32%, 69.60%）; VES and paclitaxel both induced apoptosis of MDA-MB-453 cells, and it is dose to time dependence. It was strongest in apoptosis at 10 mg/L VES and 100 nmol/L paclitaxel in MDA-MB-453 cells 48 h later. Conclusion： VES and paclitaxel both induced apoptosis of MDA-MB-453 cells. It is stronger when the two drugs are administrated together. The mechanism is probably related to reduction of bcl-2 expression, so as to be more sensitive to paclitaxel. Synergistic effect is also possible for the two drugs influence tumor cells in different growing phases.展开更多
基金Supported by a grant from the Educational Department of Province Heilonjiang (No. 11521185)
文摘Objective： The aim of this study was to detect apoptosis rates of Her-2 overexpression breast cancer cells, which were administrated with vitamin E succinate （VES） combined with paclitaxel at different dosages, or administrated alone; to discuss the mechanism of their actions. Methods： Using immunohistochemical method to detect Her-2 expression of MDA- MB-453 cells. Using TUNEL assay to detect apoptosis rates of MDA-MB-453 ceils, with the concentrations at 10, 20 mg/L of VES and 50, 100 nmol/L of paclitaxel, and also combined together for 24 or 48 h. Then compared apoptosis action of various combinations. Results： The expression rate of 95% Her-2 was interval （63.32%, 69.60%）; VES and paclitaxel both induced apoptosis of MDA-MB-453 cells, and it is dose to time dependence. It was strongest in apoptosis at 10 mg/L VES and 100 nmol/L paclitaxel in MDA-MB-453 cells 48 h later. Conclusion： VES and paclitaxel both induced apoptosis of MDA-MB-453 cells. It is stronger when the two drugs are administrated together. The mechanism is probably related to reduction of bcl-2 expression, so as to be more sensitive to paclitaxel. Synergistic effect is also possible for the two drugs influence tumor cells in different growing phases.
